These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2859148)

  • 1. A review of neuropathological and neurochemical correlates of Alzheimer's disease.
    Perry EK; Perry RH
    Dan Med Bull; 1985 Feb; 32 Suppl 1():27-34. PubMed ID: 2859148
    [No Abstract]   [Full Text] [Related]  

  • 2. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
    Wilcock GK; Esiri MM; Bowen DM; Hughes AO
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 4. Some unanswered questions about the mechanisms and etiology of Alzheimer's disease.
    Terry RD
    Dan Med Bull; 1985 Feb; 32 Suppl 1():22-4. PubMed ID: 2859147
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathologic anatomy of senile dementia of the Alzheimer type].
    Probst A
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):97-8. PubMed ID: 2413544
    [No Abstract]   [Full Text] [Related]  

  • 6. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
    Förstl H; Levy R; Burns A; Luthert P; Cairns N
    Pharmacopsychiatry; 1994 Jan; 27(1):11-5. PubMed ID: 8159776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.
    Pearson RC; Powell TP
    J Neural Transm Suppl; 1987; 24():139-46. PubMed ID: 3119773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():125-35. PubMed ID: 2411933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacology of Alzheimer's disease.
    Procter AW
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):191-4. PubMed ID: 8777499
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
    Mann DM; Yates PO; Marcyniuk B
    Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    Neurosci Lett; 1985 May; 56(1):51-5. PubMed ID: 4011048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of current concepts of Alzheimer's disease.
    Schneck MK; Reisberg B; Ferris SH
    Am J Psychiatry; 1982 Feb; 139(2):165-73. PubMed ID: 6119911
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuropathology of aminergic nuclei in Alzheimer's disease.
    Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
    Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senile dementia of the Alzheimer type.
    Terry RD; Katzman R
    Ann Neurol; 1983 Nov; 14(5):497-506. PubMed ID: 6139975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F; Pilleri G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T; Bigl V; Tennstedt A; Arendt A
    Neurosci Lett; 1984 Jul; 48(1):81-5. PubMed ID: 6472737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.